Literature DB >> 10823670

Identification of the crude drug atractylodes rhizome (Byaku-jutsu) and atractylodes lancea rhizome (So-jutsu) using chloroplast TrnK sequence as a molecular marker.

H Mizukami1, Y Okabe, H Kohda, N Hiraoka.   

Abstract

Novel methods for molecular authentication of Atractylodes-derived crude drugs (Jutsu) were established based on PCR-restriction fragment length polymorphism (RFLP) and direct sequencing of chloroplast trnK. Two regions inside the chloroplast trnK were selected as molecular markers for identification and discrimination of Atractylodes Rhizome (Byaku-jutsu) and Atractylodes Lancea Rhizome (So-jutsu). The Region 1 fragment (260 bp) amplified from So-jutsu and Wa-byaku-jutsu (Atractylodes Rhizome derived from A. japonica) gave 2 bands of 180 bp and 80 bp on agarose gel electrophoresis after digestion with a restriction endonuclease HinfI, whereas the fragment amplified from Kara-byaku-jutsu (Atractylodes Rhizome derived from A. ovata) remained undigested, which allowed unambiguous identification of Kara-byaku-jutsu. By direct sequencing of Region 2 (436 bp) and comparison of the nucleotide sequence data sets we could not only discriminate Byaku-jutsu and So-jutsu but also identify the original plant species of each crude drug specimen. A simple and reliable protocol for rapid preparation of DNA suitable for PCR from as little as 1 mg of Atractylodes-derived crude drugs was also described.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10823670     DOI: 10.1248/bpb.23.589

Source DB:  PubMed          Journal:  Biol Pharm Bull        ISSN: 0918-6158            Impact factor:   2.233


  2 in total

1.  Genetic and environmental factors influencing the contents of essential oil compounds in Atractylodes lancea.

Authors:  Takahiro Tsusaka; Bunsho Makino; Ryo Ohsawa; Hiroshi Ezura
Journal:  PLoS One       Date:  2019-05-28       Impact factor: 3.240

2.  DNA methods for identification of Chinese medicinal materials.

Authors:  Pui Ying Yip; Chi Fai Chau; Chun Yin Mak; Hoi Shan Kwan
Journal:  Chin Med       Date:  2007-09-05       Impact factor: 5.455

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.